BioCentury
ARTICLE | Clinical News

PEG-IFN lambda: Interim Phase IIb data

November 19, 2012 8:00 AM UTC

Interim data from 41 treatment-naïve patients with chronic HCV genotype 1 infection in the double-blind, international Phase IIb D-LITE trial showed that 90% (n=37) of patients achieved a protocol def...